Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Novel quinoline imidazole ligand enables high-yield asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Novel 5,5'-linked biphenyl ligands offering high stereoselectivity. Optimized synthesis for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN113999207B reveals efficient synthesis of pyridyl-containing chiral NNN ligands via asymmetric hydrogenation, offering cost-effective routes for pharmaceutical intermediates.
Novel route for C2-symmetric diamines using tert-butylsulfinamide. High yield, scalable process for pharma intermediates.
Novel 3-step synthesis of chiral imidazolone NHC precursors from bromoacetyl bromide. Enhances asymmetric catalysis efficiency and reduces manufacturing costs for pharmaceutical intermediates.
Novel patent CN110218227A offers mild conditions for aryl ketone derivatives ensuring supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Novel quinoline-substituted ligand enables high ee asymmetric trifluoromethylation. Cost-effective synthesis for pharmaceutical intermediate manufacturing supply chain.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
This patent introduces a novel dual-chiral ligand enabling high enantioselectivity in asymmetric catalysis, offering significant cost reduction and supply chain reliability for API intermediates manufacturing.
Patent CN119306765B enables high-yield asymmetric synthesis of florfenicol and chloramphenicol intermediates with superior stereoselectivity and scalable catalytic efficiency.
Patent CN114057717B introduces a novel quinoline-substituted bisoxazoline ligand achieving high enantioselectivity in asymmetric catalysis with mild industrial-scale synthesis conditions.
Novel axial chiral phosphine-ene ligand enables mild-condition asymmetric allylation with high yield and enantioselectivity, ensuring reliable supply chain for pharmaceutical intermediates.
Patent CN118666838B enables high-purity chiral intermediates through copper-catalyzed asymmetric synthesis, offering streamlined manufacturing and enhanced supply chain reliability for pharmaceutical applications.
Novel indole-skeleton phosphine ligand enables high-yield C-S bond formation with reduced catalyst loading, offering significant supply chain reliability for pharmaceutical intermediates.
Patent CN111718372B enables high-purity fine chemical production through innovative ligand technology with reduced lead time and scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN111909016B enables high-purity cyclohexene intermediates with exceptional enantioselectivity through novel chiral ligand catalysis and streamlined production process.
Innovative benzofuran-based phosphine ligand enables high-yield Suzuki-Miyaura coupling with simplified synthesis, reducing manufacturing costs and improving supply chain reliability for fine chemicals.